Food Lipids: Chemistry, Nutrition, and Biotechnology

35. D. R. Janero. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices
of lipid peroxidation and peroxidative tissue injury. Free Rad. Biol. Med. 9:515 (1990).
36. W. Palinsky, M. E. Rosenfeld, S. Ylä-Herttuala, G. C. Gurtner, S. S. Socher, S. W.
Butler, S. Parthasarathy, T. E. Carew, D. Steinberg, and J. L. Witztum. Low density
lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA 86:
1372 (1989).
37. S. Ylä-Herttuala, W. Palinsky, M. E. Rosenfeld, S. Parthasarathy, T. E. Carew, S. Butler,
J. L. Witztum, and D. Steinberg. Evidence for the presence of oxidatively modified low
density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1086
(1989).
38. P. Holvoet, G. Perez, Z. Zhao, E. Brouwers, H. Bernar, and D. Collen. Malondialdehydemodified
low density lipoproteins in patients with atherosclerotic disease. J. Clin. Invest.
95:2611 (1995).
39. D. Pratico. F2-isoprostanes: Sensitive and specific non-invasive indices of lipid peroxidation
in vivo. Atherosclerosis 147:1–10 (1999).
40. G. Davi, P. Alessandrini, A. Mezzetti, G. Minotti, T. Bucciarelli, F. Costantini, F. Cipollone,
G. G. Bittolo-Bon, G. Ciabattoni, and C. Patrono. In vivo formation of 8-epiprostaglandin
F2a is increased in hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol.
17:3230–3235 (1997).
41. G. Davi, G. Ciabattoni, A. Consoli, A. Mezzetti, A. Falco, S. Santarone, E. Pennese, E.
Vitacolonna, T. Bucciarelli, F. Costantini, F. Capani, and C. Patrono. In vivo formation
of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: Effects of
improved metabolic control and vitamin E supplementation. Circulation 99:224–229
(1999).
42. A. J. Brown and W. Jessup. Oxysterols and atherosclerosis. Atherosclerosis 142:1–28
(1999).
43. J. T. Salonen, K. Nyyssonen, R. Salonen, E. Porkkala-Sarataho, T. Tuomainen, U.
Diczfalusy, and I. Björkhem. Lipoprotein oxidation and progression of carotid atherosclerosis.
Circulation 95:840–845 (1997).
44. B. Zieden and U. Diczfalusy. Higher 7�-hydroxycholesterol in high cardiovascular risk
population. Atherosclerosis 134:172 (1997).
45. I. Staprans, X. M. Pan, J. H. Rapp, C. Grunfeld, and K. R. Feingold. Oxidized cholesterol
in the diet accelerates the development of atherosclerosis in LDL receptor– and apolipoprotein
E–deficient mice. Arterioscler. Thromb. Vasc. Biol. 20:708–714 (2000).
46. M. Abbey, G. B. Beiling, M. Noakes, F. Hirata, and P. J. Nestel. Oxidation of low
density lipoproteins: Intraindividual variability and the effect of dietary linoleate supplementation.
Am. J. Clin. Nutr. 57:391 (1993).
47. P. Reaven, S. Parthasarathy, B. J. Grasse, E. Miller, F. Almacazan, F. H. Mattson, J. C.
Khoo, D. Steinberg, and J. L. Witztum. Feasibility of using an oleate-rich diet to reduce
the susceptibility of low density lipoprotein to oxidative modification in humans. Am.
J. Clin. Nutr. 54:701 (1991).
48. S. Parthasarathy, J. C. Khoo, E. Miller, J. Barnett, J. L. Whitztum, and D. Steinberg.
Low density lipoprotein rich in oleic acid is protected against oxidative modification:
Implications for dietary prevention of atherosclerosis. Proc. Natl. Acad. Sci. USA 87:
3894 (1990).
49. P. Reaven, S. Parthasarathy, B. J. Grasse, E. Miller, D. Steinberg, and J. L. Witztum.
Effects of oleate rich and linoleate rich diets on the susceptibility of low density lipoprotein
to oxidative modification in mildly hypercholesterolemic subjects. J. Clin. Invest.
91:668 (1993).
50. K. D. Croft, P. Williams, S. Dimmitt, R. Abu-Amsha, and L. J. Beilin. Oxidation of low
density lipoproteins: Effect of antioxidant content, fatty acid composition and intrinsic
Copyright 2002 by Marcel Dekker, Inc. All Rights Reserved.